Last updated: 1 August 2024 at 12:48pm EST

Lewis Titterton Net Worth




The estimated Net Worth of Lewis H Jr Titterton is at least $3.56 Million dollars as of 30 July 2024. Mr. Titterton owns over 27,226 units of Anixa Biosciences stock worth over $2,769,672 and over the last 9 years he sold ANIX stock worth over $651,000. In addition, he makes $136,575 as Lead Independent Director at Anixa Biosciences.

Mr. Titterton ANIX stock SEC Form 4 insiders trading

Lewis has made over 41 trades of the Anixa Biosciences stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 27,226 units of ANIX stock worth $84,128 on 30 July 2024.

The largest trade he's ever made was selling 210,000 units of Anixa Biosciences stock on 24 August 2016 worth over $651,000. On average, Lewis trades about 15,320 units every 57 days since 2015. As of 30 July 2024 he still owns at least 896,334 units of Anixa Biosciences stock.

You can see the complete history of Mr. Titterton stock trades at the bottom of the page.





Lewis Titterton biography

Lewis H. Titterton Jr. serves as Lead Independent Director of the Company. His background is in high technology with an emphasis on health care and he was the Chairman of the Board of Directors of NYMED, Inc., a diversified health services company, from 1989 until October 2018. Mr. Titterton founded MedE America, Inc. in 1986 and was Chief Executive Officer of Management and Planning Services, Inc. from 1978 to 1986. Mr. Titterton also served as one of our Directors from July 1999 to January 2003. He holds an MBA from the State University of New York at Albany, and a B.A. degree from Cornell University. Mr. Titterton has been involved with our Company as a director or investor for over twenty years. Mr. Titterton also has substantial experience with advising on the strategic development of technology companies and over forty years of experience in various aspects of the technology industry.

What is the salary of Lewis Titterton?

As the Lead Independent Director of Anixa Biosciences, the total compensation of Lewis Titterton at Anixa Biosciences is $136,575. There are 5 executives at Anixa Biosciences getting paid more, with Dr. Amit Kumar Ph.D. having the highest compensation of $720,865.



How old is Lewis Titterton?

Lewis Titterton is 75, he's been the Lead Independent Director of Anixa Biosciences since 2018. There are no older and 10 younger executives at Anixa Biosciences.

What's Lewis Titterton's mailing address?

Lewis's mailing address filed with the SEC is C/O ANIXA BIOSCIENCES, INC., 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE,, CA, 95118.

Insiders trading at Anixa Biosciences

Over the last 6 years, insiders at Anixa Biosciences have traded over $0 worth of Anixa Biosciences stock and bought 834,156 units worth $2,822,805 . The most active insiders traders include Amit Kumar, Lewis H Jr Titterton, and Arnold M Baskies. On average, Anixa Biosciences executives and independent directors trade stock every 31 days with the average trade being worth of $78,894. The most recent stock trade was executed by Lewis H Jr Titterton on 30 July 2024, trading 27,226 units of ANIX stock currently worth $84,128.



What does Anixa Biosciences do?

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.



What does Anixa Biosciences's logo look like?

Anixa Biosciences, Inc. logo

Complete history of Mr. Titterton stock trades at ParkerVision and Anixa Biosciences

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
30 Jul 2024 Lewis H Jr Titterton
Director
Buy 27,226 $3.09 $84,128
30 Jul 2024
896,334
25 Jul 2024 Lewis H Jr Titterton
Director
Buy 8,496 $3.01 $25,573
25 Jul 2024
869,108
14 Jun 2024 Lewis H Jr Titterton
Director
Buy 4,000 $2.68 $10,720
14 Jun 2024
860,612
13 Jun 2024 Lewis H Jr Titterton
Director
Buy 405 $2.70 $1,094
13 Jun 2024
856,612
10 Jun 2024 Lewis H Jr Titterton
Director
Buy 7,432 $2.66 $19,769
10 Jun 2024
856,207
7 Jun 2024 Lewis H Jr Titterton
Director
Buy 10,738 $2.52 $27,060
7 Jun 2024
848,775
9 Apr 2024 Lewis H Jr Titterton
Director
Buy 15,009 $3.28 $49,230
9 Apr 2024
838,037
10 Oct 2023 Lewis H Jr Titterton
Director
Option 16,000 $2.58 $41,280
10 Oct 2023
823,028
27 Jul 2023 Lewis H Jr Titterton
Director
Option 120,000 $2.58 $309,600
27 Jul 2023
894,070
29 Sep 2022 Lewis H Jr Titterton
Director
Option 40,000 $2.58 $103,200
29 Sep 2022
774,070
24 Jun 2022 Lewis H Jr Titterton
Director
Option 46,000 $2.58 $118,680
24 Jun 2022
1,034,070
26 Apr 2022 Lewis H Jr Titterton
Director
Buy 10,000 $2.79 $27,900
26 Apr 2022
988,070
12 Jan 2022 Lewis H Jr Titterton
Director
Buy 5,000 $3.28 $16,400
12 Jan 2022
978,070
11 Jan 2022 Lewis H Jr Titterton
Director
Buy 2,000 $3.20 $6,400
11 Jan 2022
973,070
10 Jan 2022 Lewis H Jr Titterton
Director
Buy 6,000 $3.08 $18,480
10 Jan 2022
971,070
7 Jan 2022 Lewis H Jr Titterton
Director
Buy 11,000 $3.08 $33,880
7 Jan 2022
965,070
29 Oct 2021 Lewis H Jr Titterton
Director
Buy 18,244 $4.76 $86,841
29 Oct 2021
954,070
26 Jul 2021 Lewis H Jr Titterton
Director
Buy 30,000 $4.21 $126,300
26 Jul 2021
935,826
15 Jul 2021 Lewis H Jr Titterton
Director
Buy 12,200 $3.99 $48,678
15 Jul 2021
905,826
14 Jul 2021 Lewis H Jr Titterton
Director
Buy 23,300 $3.72 $86,676
14 Jul 2021
893,626
19 Apr 2021 Lewis H Jr Titterton
Director
Buy 5,000 $3.99 $19,950
19 Apr 2021
870,326
25 Mar 2021 Lewis H Jr Titterton
Director
Buy 45,000 $4.84 $217,800
25 Mar 2021
865,326
11 Sep 2020 Lewis H Jr Titterton
Director
Buy 40,000 $2.08 $83,200
11 Sep 2020
1,020,326
16 Jun 2020 Lewis H Jr Titterton
Director
Buy 24,500 $2.27 $55,615
16 Jun 2020
980,326
15 Jun 2020 Lewis H Jr Titterton
Director
Buy 31,083 $2.27 $70,558
15 Jun 2020
955,826
13 Mar 2020 Lewis H Jr Titterton
Director
Buy 5,799 $2.12 $12,294
13 Mar 2020
924,743
15 Jan 2020 Lewis H Jr Titterton
Director
Buy 5,000 $3.32 $16,600
15 Jan 2020
918,944
14 Jan 2020 Lewis H Jr Titterton
Director
Buy 7,400 $3.22 $23,828
14 Jan 2020
913,944
13 Sep 2019 Lewis H Jr Titterton
Director
Buy 15,000 $4.10 $61,500
13 Sep 2019
906,544
22 Apr 2019 Lewis H Jr Titterton
Director
Buy 50,000 $4.09 $204,500
22 Apr 2019
891,544
25 Oct 2018 Lewis H Jr Titterton
Director
Buy 2,000 $4.05 $8,100
25 Oct 2018
841,544


Anixa Biosciences executives and stock owners

Anixa Biosciences executives and other stock owners filed with the SEC include: